These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24295895)

  • 21. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxcarbazepine add-on in the treatment of refractory bipolar disorder.
    Pratoomsri W; Yatham LN; Sohn CH; Solomons K; Lam RW
    Bipolar Disord; 2005; 7 Suppl 5():37-42. PubMed ID: 16225559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment and course of different subtypes of status epilepticus.
    Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
    Epilepsy Res; 2013 Nov; 107(1-2):156-62. PubMed ID: 24016689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous levetiracetam as treatment for status epilepticus.
    Berning S; Boesebeck F; van Baalen A; Kellinghaus C
    J Neurol; 2009 Oct; 256(10):1634-42. PubMed ID: 19458986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine in combination with Tiaprid in inpatient alcohol-withdrawal--a RCT.
    Croissant B; Loeber S; Diehl A; Nakovics H; Wagner F; Kiefer F; Mann K
    Pharmacopsychiatry; 2009 Sep; 42(5):175-81. PubMed ID: 19724979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A "malignant" variant of status epilepticus.
    Holtkamp M; Othman J; Buchheim K; Masuhr F; Schielke E; Meierkord H
    Arch Neurol; 2005 Sep; 62(9):1428-31. PubMed ID: 16157750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the efficacy and tolerability of oxcarbazepine oral suspension between infants and children with epilepsy: a retrospective chart review at a single medical center in Taiwan.
    Wei SH; Liu CC; Fan PC
    Paediatr Drugs; 2014 Feb; 16(1):83-9. PubMed ID: 24081427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cost comparison of alternative regimens for treatment-refractory partial seizure disorder: an econometric analysis.
    Lee WC; Hoffmann MS; Arcona S; D'Souza J; Wang Q; Pashos CL
    Clin Ther; 2005 Oct; 27(10):1629-38. PubMed ID: 16330300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
    Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
    Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures.
    Kraiprab P; Chinvarun Y; Tantisira MH
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S193-201. PubMed ID: 16858958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.
    Azar NJ; Wang L; Song Y; Abou-Khalil BW
    Epilepsy Res; 2008 Mar; 79(1):78-83. PubMed ID: 18281195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term assessment of oxcarbazepine in a naturalistic setting: a retrospective study.
    Seneviratne U; D'Souza W; Cook M
    Acta Neurol Scand; 2008 May; 117(5):367-9. PubMed ID: 18028241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxcarbazepine improves mood in patients with epilepsy.
    Mazza M; Della Marca G; Di Nicola M; Martinotti G; Pozzi G; Janiri L; Bria P; Mazza S
    Epilepsy Behav; 2007 May; 10(3):397-401. PubMed ID: 17300991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S; Grumbt M; Müller M; Schulze A
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
    Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
    Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine use in the treatment of refractory status epilepticus.
    Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.